Second Malignancy Probabilities in Patients With Breast Cancer Treated With Conventional Versus Hypofractionated External Beam Radiation Therapy in the Adjuvant Setting

CONCLUSIONS: In this analysis of over 120 000 women with non-metastatic breast cancer, hEBRT was not associated with different odds of developing second malignancies compared with cEBRT. Our findings may inform patient counselling in the choice of radiation regimens for breast cancer and further support the safety of hypofractionated regimens for breast cancer.PMID:38184401 | DOI:10.1016/j.clon.2023.12.002

Source: Clinical Genitourinary Cancer - January 6, 2024 Category: Cancer & Oncology Authors: T A Patel B Jain H L Cho C Corti N Vapiwala F Chino J E Leeman E C Dee Source Type: research